KAZIA THERAPEUTICS LTD (KZIA)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch KZIA
See up to 3 months of KZIA. The 7-day demo opens the 1M and 3M ranges and puts KZIA on your watchlist.
Start 7-day demoLatest KZIA insider trades
Steven R. S. Coffey - DirectorGrant or award100,000 sh- John E. Friend II - OfficerGrant or award500,000 sh
- John E. Friend II - Officer
About KAZIA THERAPEUTICS LTD (KZIA)
The SEC lists KAZIA THERAPEUTICS LTD under CIK 0001075880, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector. It filed a registration statement with the SEC on 19 December 2025 and has not yet priced an offering.
KZIA Form 4 activity by transaction type, last 90 days
No Form 4 activity for KZIA in the last 90 days.
KZIA insider transactions (Form 4)
98 Form 4 filings on record, the earliest from Jun 23, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Steven R. S. Coffey - Director | Grant or award | Employee Stock Option (right to buy) | 100,000 footnote F1 | $0.00 | - | |
| ||||||
| John E. Friend II - Officer | Grant or award | Employee Stock Option (right to buy) | 500,000 footnote F1 | $0.00 | - | |
| John E. Friend II - Officer | Grant or award | Restricted Share Units | 150,000 | $0.00 | - | |
| ||||||
| Jeffrey Bonacorda - Officer | Grant or award | Employee Stock Option (right to buy) | 150,000 footnote F1 | $0.00 | - | |
| ||||||
| Ebru Davidson - Director | Grant or award | Employee Stock Option (right to buy) | 100,000 footnote F1 | $0.00 | - | |
| ||||||
| David Cain - Officer | Grant or award | Employee Stock Option (right to buy) | 100,000 footnote F1 | $0.00 | - | |
| ||||||
 Robert F. Apple - Director | Grant or award | Employee Stock Option (right to buy) | 75,000 footnote F1 | $0.00 | - | |
| ||||||
| James E. Levine - Officer | Grant or award | Employee Stock Option (right to buy) | 200,000 footnote F1 | $0.00 | - | |
| ||||||
| Sudha Rao - Officer | Grant or award | Employee Stock Option (right to buy) | 250,000 footnote F1 | $0.00 | - | |
| ||||||
KZIA insider trading FAQ
What is the latest insider trade for KZIA?
KAZIA THERAPEUTICS LTD (KZIA) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-07-08. The full record for KZIA runs to 8 Form 4 filings, the earliest from 2026-06-23. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying KZIA stock?
No insider purchases of KZIA were filed in the last 90 days.
How many insiders are selling KZIA stock?
No insider sales of KZIA were filed in the last 90 days.
Where can I see KZIA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects KZIA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
8The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Steven R. S. Coffey view on EDGAR
- - John E. Friend II view on EDGAR
- - Jeffrey Bonacorda view on EDGAR
- - Ebru Davidson view on EDGAR
- - David Cain view on EDGAR
- - Robert F. Apple view on EDGAR
- - James E. Levine view on EDGAR
- - Sudha Rao view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where KZIA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow KZIA with a 7-day demo
- KZIA on your watchlist
- Every KZIA Form 4 filing on record
- Up to 3 months of KZIA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
